Sheba Medical Center and Enlivex Announce Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Combined with Chemotherapy in Patients with Peritoneal Metastases Arising from Solid Cancers
Similar Posts
Independent Physicians Keep Healthcare Costs Low, Provide Great Care and Improve Patient Satisfaction
Kareo and Independent Physicians Respond to Kocher Editorial in Wall Street Journal with an “Amen!” In an op-ed piece…
Excellus BlueCross BlueShield And Geneia Partner On Value-Based Analytics
Geneia, an analytics and emerging technology leader in transforming healthcare delivery, announced today that Rochester, N.Y.-based Excellus BlueCross BlueShield…
CONNECTIONS™ Summit at CES® Examines New Consumer Electronics Emerging from IoT and Cloud-Based Services
Parks Associates Announces Topics and Call for Papers for 11th-annual executive event Parks Associates today announced the agenda and…
St. Joseph Hoag Health Joins the California Integrated Data Exchange
Largest provider of healthcare in Orange County to participate in statewide health information exchange The California Integrated Data Exchange…
5 Quick & Simple Mental Exercises To Try During Stressful Times
Pellentesque diam volutpat commodo sed egestas. Tellus elementum sagittis vitae et leo duis ut diam quam. Eleifend donec pretium…
